| Study to Assess the Prophylactic Efficacy and Safety of Sebaloxavir Marboxil Tablets/Oral Suspension for Influenza Prevention in Household Contacts Aged ≥2 Years. (NCT07730346) | Nanjing Zenshine Pharmaceuticals | 2026-11-07 |
| Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of ZX-8177 in Patients With Advanced Solid Tumors (NCT07310134) | Nanjing Zenshine Pharmaceuticals | 2025-12-26 |
| Study to Assess the Safety and Efficacy of ZX-7101A for Oral Suspension in Chinese Pediatric Participants 2 to 11 Years of Age With Influenza (NCT07095257) | Nanjing Zenshine Pharmaceuticals | 2025-10-13 |
| Study to Evaluate the Pharmacokinetics and Relative Bioavailability of Metabolites in Healthy Chinese Adult Males (NCT06841926) | Nanjing Zenshine Pharmaceuticals | 2025-02-20 |
| Study to Assess the Safety and Efficacy of ZX-7101A in Children Aged 5-11 Years With Influenza (NCT06669351) | Nanjing Zenshine Pharmaceuticals | 2024-10-31 |
| A Study to Evaluate Drug-drug Interaction of ZX-7101A Tablets and Oseltamivir Phosphate Capsules in Healthy Adult Subjects (NCT06057103) | Nanjing Zenshine Pharmaceuticals | 2023-08-28 |
| A Study to Evaluate the Effect of a Single Oral Dose of ZX-7101A on the QTc Interval in Healthy Subjects (NCT05955027) | Nanjing Zenshine Pharmaceuticals | 2023-07-08 |
| A Study to Assess the Effect of Itraconazole Capsules on the Pharmacokinetics of ZX-7101A Tablets in Healthy Adult Subjects in China (NCT05949385) | Nanjing Zenshine Pharmaceuticals | 2023-07-02 |
| Pharmacokinetic Characteristics of Subjects with Hepatic Insufficiency and Healthy Subjects (NCT05711797) | Nanjing Zenshine Pharmaceuticals | 2023-04-12 |
| Substance Balance Study of [14C]ZX-7101A in Healthy Adult Male Subjects in China (NCT05720091) | Nanjing Zenshine Pharmaceuticals | 2023-02-14 |
| A Study to Evaluate the Efficacy and Safety of ZX-7101A Tablets in Adults with Uncomplicated Influenza (NCT05702489) | Nanjing Zenshine Pharmaceuticals | 2022-07-17 |
| A Study to Evaluate the Activity, Safety and Tolerability of ZX-101A in Advanced Solid Tumors (NCT05258266) | Nanjing Zenshine Pharmaceuticals | 2022-03-09 |
| A Study to Evaluate Activity, Safety and Tolerability of ZX-101A in Relapsed/Refractory Hematological Malignancies (NCT05269940) | Nanjing Zenshine Pharmaceuticals | 2022-02-17 |
| Dose-Escalation and Dose-Expansion Study of ZX-4081 in Patients With Advanced Solid Tumors (NCT05118841) | Nanjing Zenshine Pharmaceuticals | 2022-01-03 |
| Study to Assess the Safety, Tolerability and Pharmacokinetics of ZX-7101A and the Food Effect in Healthy Volunteers (NCT05217732) | Nanjing Zenshine Pharmaceuticals | 2021-12-01 |